PASSAGE BIO, INC.

PASG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $24.2M $33.3M $46.3M $52.8M $57.6M $63.4M $37.6M $32.3M
Accounts Receivable
Inventory
Total Current Assets $25.2M $34.7M $47.8M $55.7M $60.3M $66.7M $78.8M $87.2M
Property, Plant & Equipment $826.0K $4.1M $5.2M $5.3M $5.5M $9.3M $10.0M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $25.2M $36.5M $62.3M $74.2M $79.2M $86.0M $102.4M $111.8M
Liabilities
Accounts Payable $902.0K $1.3M $1.1M $952.0K $2.4M $1.5M $742.0K $1.5M
Total Current Liabilities $20.7M $20.1M $23.1M $22.2M $19.8M $17.8M $19.4M $17.0M
Long-Term Debt
Total Liabilities $20.7M $24.7M $43.5M $43.0M $40.9M $39.3M $41.2M $39.0M
Stockholders' Equity
Retained Earnings $-720.1M $-712.3M $-704.8M $-691.8M $-684.0M $-674.6M $-659.2M $-646.5M
Total Stockholders' Equity $4.5M $11.8M $18.8M $31.1M $38.3M $46.7M $61.3M $72.7M
← Newer Page 1 of 4 Older →